Searched for
RICHARD SAYNOR SANDOZ
Sandoz bets big on biosimilars, aims to double group sales by 2035Sandoz plans to more than double annual net sales by 2035, with biosimilars leading growth. The company will expand its biosimilar portfoli...
Trump’s 100% generic drug duty threatens US low-cost supplyPresident Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...
Trump’s $1.4 trillion tariff threat spurs companies to seek coverCompanies like Novo Nordisk, Boeing, and Walmart are preparing for the impacts of President Donald Trump’s tariffs. Executives are assessin...